Stealth BioTherapeutics Corp MITO
0.32 +0.32
Day range unavailable
52-week range unavailable
News
prnewswire.com FGR accelerates USA expansion & defence sector exposure with strategic acquisition of MITO® Material Solutions Highlights FGR enters binding agreement to acquire all assets, intellectual property, product lines and manufacturing capabilities of USA-based MITO ® Material Solutions, Inc. Strategic acquisition…
prnewswire.com Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome NEEDHAM, Mass. , Sept. 19, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development and…
prnewswire.com STEALTH BIOTHERAPEUTICS RESUBMITS NEW DRUG APPLICATION FOR ELAMIPRETIDE FOR THE TREATMENT OF BARTH SYNDROME NEEDHAM, Mass. , Aug. 18, 2025 /PRNewswire/ -- Stealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for…
reuters.com US FDA asks Stealth BioTherapeutics to resubmit application for rare genetic condition therapy The U.S. Food and Drug Administration has asked for a resubmission of Stealth BioTherapeutics' marketing application for its experimental therapy targeting a rare genetic condition, Barth syndrome,…
reuters.com FDA delays decision on Stealth BioTherapeutics' rare genetic disorder drug The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment for a rare genetic condition that typically affects boys, the drug…
prnewswire.com Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome – New PDUFA Action Date of April 29, 2025, Allows FDA Additional Time to Complete Review – – Follows Positive FDA Advisory Committee Meeting Vote Concluding that Elamipretide is Effective for the…
prnewswire.com STEALTH BIOTHERAPEUTICS' BARTH SYNDROME NDA RECEIVES PRIORITY REVIEW DESIGNATION Barth Syndrome is an Ultra-rare, Progressive, Life-Shortening, Cardioskeletal Disease that Affects Approximately 150 Individuals in the United States If Approved, Elamipretide Would Become the First…
prnewswire.com Stealth BioTherapeutics to Present at JMP Citizens Life Sciences Conference NEEDHAM, Mass. , May 6, 2024 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and…
prnewswire.com STEALTH BIOTHERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR ELAMIPRETIDE FOR THE TREATMENT OF BARTH SYNDROME Barth Syndrome is an Ultra-rare, Progressive, Life-Shortening, Cardioskeletal Disease that Affects Approximately 150 Individuals in the United States If Approved, Elamipretide Would Become the First…
prnewswire.com Stealth BioTherapeutics to Present at the Baird 2023 Biotech Discovery Series NEEDHAM, Mass. , Dec. 4, 2023 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development, and…
benzinga.com Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
pennystocks.com Good Penny Stocks to Buy Today? 3 to Watch Right Now Here are three penny stocks to watch right now The post Good Penny Stocks to Buy Today? 3 to Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
benzinga.com Why Stealth BioTherapeutics Shares Are Surging Today? Stealth BioTherapeutics Corp (NASDAQ: MITO) presented new SBT-272 preclinical data demonstrating functional improvement in upper motor neurons with TDP-43 pathology. TDP-43 pathology plays a…
benzinga.com 77 Biggest Movers From Yesterday Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an…
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 215 companies set new 52-week lows.
benzinga.com 110 Biggest Movers From Friday Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.- benzinga.com 56 Stocks Moving In Friday's Mid-Day Session Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to…
pennystocks.com What to Know About Buying Penny Stocks on May 10th Here's what you need to know about trading penny stocks today The post What to Know About Buying Penny Stocks on May 10th appeared first on Penny Stocks to Buy, Picks, News and Information |…
benzinga.com 90 Biggest Movers From Yesterday Gainers
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 351 stocks hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's trading, 435 companies set new 52-week lows.
benzinga.com Stealth Bio Posts Disappointing Elamipretide Data From Mid-Stage Geographic Atrophy Study Stealth BioTherapeutics Corp (NASDAQ: MITO) has announced topline data from its Phase 2 ReCLAIM-2 trial evaluating elamipretide in geographic atrophy (GA) secondary to dry age-related macular…
benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 213 companies hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday's session saw 784 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 431 companies hit new 52-week lows.
benzinga.com 58 Biggest Movers From Yesterday Gainers- benzinga.com 32 Stocks Moving in Wednesday's Pre-Market Session Gainers Zentek Ltd. (NASDAQ: ZTEK) rose 180.5% to $7.63 in pre-market trading after declining around 5% on Tuesday.
prnewswire.com Stealth BioTherapeutics to Present at Upcoming March Investor Conferences BOSTON , March 9, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel…- benzinga.com 63 Biggest Movers From Yesterday Gainers Tenneco Inc. (NYSE: TEN) shares surged 93.9% to close at $19.35 on Wednesday after the company announced it will be acquired by Apollo Funds. Tenneco also reported a Q4 loss of $0.11 per…
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's trading, 505 companies set new 52-week lows.
prnewswire.com Stealth BioTherapeutics to Present at Mitochondria-Targeted Drug Development Summit BOSTON, Feb. 22, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel…- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 313 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks
prnewswire.com Stealth BioTherapeutics to Present at 2022 H.C. Wainwright BioConnect Virtual Conference BOSTON, Jan. 4, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel…
seekingalpha.com Stealth BioTherapeutics Corp (MITO) CEO Reenie McCarthy on Q3 2021 Results - Earnings Call Transcript Stealth BioTherapeutics Corp (MITO) CEO Reenie McCarthy on Q3 2021 Results - Earnings Call Transcript- benzinga.com Earnings Scheduled For November 11, 2021 Companies Reporting Before The Bell • NICE (NASDAQ:NICE) is likely to report quarterly earnings at $1.58 per share on revenue of $465.75 million.
benzinga.com Stealth Bio Stock Falls On FDA Refusal to File Letter For Barth Syndrome Candidate Stealth BioTherapeutics Corp (NASDAQ: MITO) has received a Refusal to File letter from the FDA regarding its marketing application for elamipretide, a mitochondria-targeted therapy for Barth…
prnewswire.com Stealth BioTherapeutics Presents Positive SBT-272 Preclinical Data at 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting BOSTON, Oct. 7, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies…- benzinga.com Earnings Scheduled For August 5, 2021 Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
- benzinga.com 66 Biggest Movers From Yesterday Gainers
- benzinga.com 40 Stocks Moving In Wednesday's Mid-Day Session Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously disclosed heavily pretreated…
benzinga.com 58 Biggest Movers From Yesterday Gainers BM Technologies, Inc. (NYSE: BMTX) shares climbed 26.4% to close at $11.82 on Tuesday after the company reported record Q1 results.- benzinga.com 30 Stocks Moving in Tuesday's Pre-Market Session Gainers Stealth BioTherapeutics Corp (NASDAQ: MITO) shares rose 37.8% to $1.64 in pre-market trading after the company said it will receive $30 million in added payments during 2021.
- benzinga.com Earnings Scheduled For May 18, 2021 Companies Reporting Before The Bell • Agrify (NASDAQ:AGFY) is expected to report quarterly loss at $0.31 per share on revenue of $5.80 million.
- benzinga.com 70 Biggest Movers From Friday Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday.
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com 56 Stocks Moving In Friday's Mid-Day Session Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 77% to $4.321.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Before 10 a.m. ET Friday, 62 stocks made new 52-week lows.
- benzinga.com Earnings Scheduled For November 5, 2020 Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.64 per share on revenue of $52.59 million.